Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
60 participants
INTERVENTIONAL
2021-06-22
2023-08-22
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pulse Radiofrequency and Occipital Nerve Block for Chronic Migraine Patients
NCT06247592
Comparison of the Efficacy of Ultrasound-guided Greater Occipital Nerve Block and Pulsed Radiofrequency Therapy in Chronic Migraine Patients
NCT05464212
Greater Occipital Nerve Block Versus Pulse Radiofrequency in Migraine
NCT06345326
Comparing Unilateral and Bilateral Proximal GONPRF in Migraine Treatment
NCT06894121
Efficacy of Greater Occipital Nerve Radiofrequency for Refractory Migraine Treatment
NCT05199064
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Investigator aimed to compare the efficacy of transcutaneous pulsed radiofrequency therapy applied through the GON trace and GON block therapy. A 60-patient study was designed. GON block was planned for 30 patients and transcutaneous pulsed RF was planned for 30 patients. The block will be applied once at the level of C2 vertebra with ultrasound.Transcutaneous pulsed RF will be applied twice, once a week, for 8 minutes.All patients will have pre-treatment migraine disability assessment score (MIDAS) scores filled. A headache diary will be provided to all patients. Frequency and severity of pain will be followed for 1 month. Pain intensity will be evaluated on the visual analog scale (VAS).
Investigator aimed to evaluate the efficacy of transcutaneous pulsed RF therapy, which is a noninvasive method, in migraine.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
GON block group
30 patients who underwent greater occipital nerve block
Bupivacaine Hydrochloride
2.5 cc bupivacain injection will be administered by approaching the greater occipital nerve under ultrasound guidance.
Transcutaneous pulsed RF group
30 patients who underwent greater occipital nerve pulsed radiofrequency
Transcutaneous pulsed radiofrequency qurrent
Pulsed radiofrequency current will be applied through transcutaneous pads adhered over the greater occipital nerve trace on the nape.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bupivacaine Hydrochloride
2.5 cc bupivacain injection will be administered by approaching the greater occipital nerve under ultrasound guidance.
Transcutaneous pulsed radiofrequency qurrent
Pulsed radiofrequency current will be applied through transcutaneous pads adhered over the greater occipital nerve trace on the nape.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Pregnancy
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Diskapi Teaching and Research Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Damla Yürük
Director, medical doctor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
mehlika panpallı ateş
Role: STUDY_CHAIR
Diskapi TRH
ömer taylan akkaya
Role: STUDY_DIRECTOR
Diskapi TRH
Hüseyin Alp Alptekin
Role: STUDY_CHAIR
Diskapi TRH
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Diskapi Yildirim Beyazıt Teaching and Research Hospital
Ankara, Altındğ, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Perdecioglu GRG, Ates MP, Yuruk D, Can E, Yildiz G, Akkaya OT. A new neuromodulation method in chronic migraine; non-invasive pulsed radiofrequency, a single-blinded, randomised, controlled trial. Ir J Med Sci. 2024 Jun;193(3):1487-1493. doi: 10.1007/s11845-023-03598-x. Epub 2023 Dec 26.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Transcutaneous GON
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.